Difference between revisions of "TACE"
Jump to navigation
Jump to search
m |
m |
||
| Line 1: | Line 1: | ||
| − | Transarterial chemoembolization (TACE) refers to a number of local delivery approaches which are almost exclusively used in the treatment of [[hepatocellular carcinoma]] or hepatic metastases. | + | Transarterial chemoembolization (TACE) refers to a number of local delivery approaches which are almost exclusively used in the treatment of [[hepatocellular carcinoma]] or hepatic metastases. Typically there is an inert lipid-based carrier such as lipiodol and an expander such as gelatin foam, along with chemotherapy. |
| − | Examples include (this list will be filled in over time): | + | Examples chemotherapies include (this list will be filled in over time): |
| − | *Doxorubicin | + | *Cisplatin, Doxorubicin, Epirubicin, and Mitomycin |
| + | *Doxorubicin | ||
[[Category:Chemotherapy]] | [[Category:Chemotherapy]] | ||
[[Category:Hepatocellular carcinoma medications]] | [[Category:Hepatocellular carcinoma medications]] | ||
Revision as of 14:38, 19 June 2018
Transarterial chemoembolization (TACE) refers to a number of local delivery approaches which are almost exclusively used in the treatment of hepatocellular carcinoma or hepatic metastases. Typically there is an inert lipid-based carrier such as lipiodol and an expander such as gelatin foam, along with chemotherapy.
Examples chemotherapies include (this list will be filled in over time):
- Cisplatin, Doxorubicin, Epirubicin, and Mitomycin
- Doxorubicin